1. Home
  2. ENSC vs RKDA Comparison

ENSC vs RKDA Comparison

Compare ENSC & RKDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • RKDA
  • Stock Information
  • Founded
  • ENSC 2003
  • RKDA 2002
  • Country
  • ENSC United States
  • RKDA United States
  • Employees
  • ENSC N/A
  • RKDA N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • RKDA Agricultural Chemicals
  • Sector
  • ENSC Health Care
  • RKDA Industrials
  • Exchange
  • ENSC Nasdaq
  • RKDA Nasdaq
  • Market Cap
  • ENSC 7.9M
  • RKDA 6.6M
  • IPO Year
  • ENSC N/A
  • RKDA 2015
  • Fundamental
  • Price
  • ENSC $5.40
  • RKDA $3.98
  • Analyst Decision
  • ENSC
  • RKDA Strong Buy
  • Analyst Count
  • ENSC 0
  • RKDA 1
  • Target Price
  • ENSC N/A
  • RKDA $6.00
  • AVG Volume (30 Days)
  • ENSC 26.4K
  • RKDA 6.3K
  • Earning Date
  • ENSC 03-14-2025
  • RKDA 03-27-2025
  • Dividend Yield
  • ENSC N/A
  • RKDA N/A
  • EPS Growth
  • ENSC N/A
  • RKDA N/A
  • EPS
  • ENSC N/A
  • RKDA N/A
  • Revenue
  • ENSC $4,421,404.00
  • RKDA $5,482,000.00
  • Revenue This Year
  • ENSC $89.78
  • RKDA N/A
  • Revenue Next Year
  • ENSC N/A
  • RKDA $30.00
  • P/E Ratio
  • ENSC N/A
  • RKDA N/A
  • Revenue Growth
  • ENSC 40.41
  • RKDA 24.00
  • 52 Week Low
  • ENSC $2.12
  • RKDA $1.85
  • 52 Week High
  • ENSC $14.67
  • RKDA $10.31
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 35.78
  • RKDA 25.98
  • Support Level
  • ENSC $5.34
  • RKDA $4.74
  • Resistance Level
  • ENSC $6.14
  • RKDA $4.85
  • Average True Range (ATR)
  • ENSC 0.43
  • RKDA 0.20
  • MACD
  • ENSC -0.04
  • RKDA -0.07
  • Stochastic Oscillator
  • ENSC 9.49
  • RKDA 13.61

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About RKDA Arcadia Biosciences Inc.

Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water and others.

Share on Social Networks: